Understanding Hashimoto's Disease Hashimoto's disease is an autoimmune condition where the immune system mistakenly attacks the thyroid gland, leading to inflammation and potential damage
A 2025 head-to-head study confirmed it: tirzepatide users lost 20.2% vs 13.7% for semaglutide
In condizioni di iperglicemia e glicogeno elevato, aumenta il malonil-CoA , che inibisce CPT1 e riduce l'ingresso degli acidi grassi nei mitocondri (favorendo la sintesi lipidica)
Comprehensive evaluation of rhythm monitoring strategies in screening for atrial fibrillation: insights from patients at risk monitored long term with an implantable loop recorder
Both options cost $30 for a one-time purchase, or $9 per month if you subscribe
The published Phase 2 trial evaluated 1 mg, 4 mg, 8 mg, and 12 mg groups with different starting-dose approaches, and gastrointestinal events were dose-related